154 related articles for article (PubMed ID: 12164773)
1. Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development.
McCarthy LC; Davies KJ; Campbell DA
Pharmacogenomics; 2002 Jul; 3(4):493-506. PubMed ID: 12164773
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics: has it reached the clinic?
Schwartz JB
J Gend Specif Med; 2002; 5(2):13-8. PubMed ID: 11974670
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and drug development: the path to safer and more effective drugs.
Roses AD
Nat Rev Genet; 2004 Sep; 5(9):645-56. PubMed ID: 15372086
[TBL] [Abstract][Full Text] [Related]
6. [Ethnic background related pharmacological differences].
Reinbold H
MMW Fortschr Med; 2007 Oct; 149(42):34, 36. PubMed ID: 17987717
[TBL] [Abstract][Full Text] [Related]
7. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
Ingelman-Sundberg M
Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of the OATP and OAT families.
Marzolini C; Tirona RG; Kim RB
Pharmacogenomics; 2004 Apr; 5(3):273-82. PubMed ID: 15102542
[TBL] [Abstract][Full Text] [Related]
10. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
[TBL] [Abstract][Full Text] [Related]
11. Population genetic structure of variable drug response.
Wilson JF; Weale ME; Smith AC; Gratrix F; Fletcher B; Thomas MG; Bradman N; Goldstein DB
Nat Genet; 2001 Nov; 29(3):265-9. PubMed ID: 11685208
[TBL] [Abstract][Full Text] [Related]
12. Global pharmacogenetics: giving the genome to the masses.
Marsh S; Van Booven DJ; McLeod HL
Pharmacogenomics; 2006 Jun; 7(4):625-31. PubMed ID: 16753009
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoanthropology: outline, problems, and the nature of case histories.
Kalow W
Fed Proc; 1984 May; 43(8):2314-8. PubMed ID: 6714439
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics in drug development.
McCarthy AD; Kennedy JL; Middleton LT
Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of drugs withdrawn from the market.
Zhang W; Roederer MW; Chen WQ; Fan L; Zhou HH
Pharmacogenomics; 2012 Jan; 13(2):223-31. PubMed ID: 22256871
[TBL] [Abstract][Full Text] [Related]
18. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics: more than skin deep.
McLeod HL
Nat Genet; 2001 Nov; 29(3):247-8. PubMed ID: 11687789
[No Abstract] [Full Text] [Related]
20. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
